These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15288479)

  • 1. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
    Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
    J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa.
    Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA
    J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
    Wang G; Huang CH; Zhao Y; Cai L; Wang Y; Xiu SJ; Jiang ZW; Yang S; Zhao T; Huang W; Gu JR
    Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
    Buendia MA
    Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
    Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
    Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping.
    Bluteau O; Beaudoin JC; Pasturaud P; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 2002 Feb; 21(8):1225-32. PubMed ID: 11850842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
    Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
    Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
    Piao Z; Kim H; Jeon BK; Lee WJ; Park C
    Cancer; 1997 Sep; 80(5):865-72. PubMed ID: 9307185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse p53 gene aberration in hepatocellular carcinoma detected by dual-color fluorescence in situ hybridization.
    Kondo M; Marusawa H; Ueda Y; Katsurada A; Kawasome C; Takami S; Kinoshita M; Ikai I; Yamaoka Y; Chiba T
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1066-73. PubMed ID: 15304126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive methylation is associated with beta-catenin mutations in hepatocellular carcinoma: evidence for two distinct pathways of human hepatocarcinogenesis.
    Nishida N; Nishimura T; Nagasaka T; Ikai I; Goel A; Boland CR
    Cancer Res; 2007 May; 67(10):4586-94. PubMed ID: 17510384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
    Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
    Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
    Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
    Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
    Shao J; Li X; Liu Z
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
    Gross-Goupil M; Riou P; Emile JF; Saffroy R; Azoulay D; Lacherade I; Receveur A; Piatier-Tonneau D; Castaing D; Debuire B; Lemoine A
    Int J Cancer; 2003 May; 104(6):745-51. PubMed ID: 12640682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma.
    Lu T; Hano H
    Liver Int; 2007 Aug; 27(6):782-90. PubMed ID: 17617121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.